Stock listing
Karyopharm Therapeutics Inc.
Selected listing: A40YLC · LS · EUR · DE
Karyopharm Therapeutics Inc. (Lang & Schwarz: A40YLC), Health Technology. Latest release Oct 1, 2026: Karyopharm Therapeutics Reports Inducement Grant Under…
- Ticker
- Lang & Schwarz: A40YLC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. (KPTI) is a public company based in the United States, focused on developing innovative therapies for cancer and other serious diseases. The company is committed to addressing unmet medical needs through its research and development efforts.
Latest news from Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2026
Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis
August 31, 2026
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
August 13, 2026
Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026
August 10, 2026
Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway
July 30, 2026
Events
Research Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. company profile
View the public company page for Karyopharm Therapeutics Inc. on 6ix.
Karyopharm Therapeutics Inc. news
Read company news and market updates connected to Karyopharm Therapeutics Inc..
Karyopharm Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Karyopharm Therapeutics Inc..
Alternate listings
KPTI:NASDAQ
US · USD
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
A40YLC:LSX
DE · EUR
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
25K0:GETTEX
DE · EUR
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
KPTI:BX
CH · CHF
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
25K0:TRADEGATE
DE · EUR
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
KPTI:BOATS
US · USD
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
25K0:DUS
DE · EUR
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
25K0:FWB
DE · EUR
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
25K0:MUN
DE · EUR
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.
25K0:SWB
DE · EUR
Alternate listing for Karyopharm Therapeutics Inc.; the primary context on this page is A40YLC:LS.